Aurobindo Pharma shares gain on U.S. FDA’s VAI classification of oral solid dosage unit
Around 2 p.m., Aurobindo Pharma shares were more than 3% higher at ₹1,475 each after touching the 52 week high of ₹1,481.80
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.